Excision of Lymph Node Trial (EXCILYNT) (Mel69)

This study aims to see if taking out just the cancerous lymph node helps stop cancer from coming back in that spot. A lymph node is a small gland that helps fight off infections. If the cancer spreads to this gland, it is called metastatic melanoma. The study also looks at any side effects from the surgery and how it affects daily life. To join, you must be at least 18 years old and have a cancerous lymph node confirmed by a CT (Computerized Tomography) or PET (Positron Emission Tomography) scan or by a doctor’s exam.

• Participation requires following all study procedures and being available for the study's entire duration.
• You must sign a consent form and be willing to follow study guidelines.
• The study is for those who have a specific type of cancerous lymph node and have not had major surgery or radiation in that area before.

If you meet these criteria and think you might want to join, talk to your doctor to see if this study is a good fit for you.